ConductScience.org, home

Paper9527282

The controlled release of antibiotic by hydroxyapatite: anionic collagen composites.

Martins VC and 4 others. Artif Organs, 1998. Cited by 38 papers, by iCite.

Cite this record

ConductScience Library. The controlled release of antibiotic by hydroxyapatite: anionic collagen composites. Papers, record 9527282. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/9527282

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The controlled release of antibiotic by hydroxyapatite: anionic collagen composites.
PubMed
Journal
Artif Organs
PubMed
Year
1998
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
38
iCite
Relative citation ratio, by iCite
1.91
iCite
Revised in PubMed
2019-08-31
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Martins VCV C
2Goissis GG
3Ribeiro ACA C
4Marcantônio E JrE
5Bet MRM R

Source PubMed

Download CSV of authors

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Anion Exchange ResinsMajor topic
Anti-Bacterial AgentsMajor topic
CollagenMajor topic
HydroxyapatitesMajor topic
Animals
Biocompatible Materials
Delayed-Action Preparations
Male
Ointments
Osteomyelitis
Rats
Spectrophotometry, Infrared

Source PubMed

Download CSV of topics

Cited by8

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 38 citations.

PMIDTitleJournalYearIn PapersSource
32283608Biologically Inspired Collagen/Apatite Composite Biomaterials for Potential Use in Bone Tissue Regeneration-A Review.Materials (Basel)2020https://conductscience.org/library/papers/32283608PubMed
31344927Oxytetracycline versus Doxycycline Collagen Sponges Designed as Potential Carrier Supports in Biomedical Applications.Pharmaceutics2019https://conductscience.org/library/papers/31344927PubMed
26262645Calcium Orthophosphate-Containing Biocomposites and Hybrid Biomaterials for Biomedical Applications.J Funct Biomater2015https://conductscience.org/library/papers/26262645PubMed
24920907Multifunctional materials for bone cancer treatment.Int J Nanomedicine2014https://conductscience.org/library/papers/24920907PubMed
23878541Application of calcium phosphate materials in dentistry.Int J Biomater2013https://conductscience.org/library/papers/23878541PubMed
23507726Biocomposites and hybrid biomaterials based on calcium orthophosphates.Biomatter2011https://conductscience.org/library/papers/23507726PubMed
19842042Organic-inorganic composites for bone drug delivery.AAPS PharmSciTech2009https://conductscience.org/library/papers/19842042PubMed
17701302Effects of calcination temperature on the drug delivery behaviour of Ibuprofen from hydroxyapatite powders.J Mater Sci Mater Med2008https://conductscience.org/library/papers/17701302PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/9527282

GET https://conductscience.org/api/papers/v1/9527282/authors